Featured Publication Accessing Improved TB Medicines for Children Click here to download the full reportResearch Papers No antimicrobial resistance research agenda without tuberculosis Treatment of Highly Drug-Resistant Pulmonary Tuberculosis Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary TuberculosisFor the PressPress Contact:Thomas Lynchp | +1 646 616 8639e | thomas.lynch@tballiance.org View the 2019 Annual Report
